Eruptive melanocytic naevi provoked by sunbed use in a patient on systemic immunosuppression
暂无分享,去创建一个
C. O'Keeffe | M. Roche | C. Feighery | A. Hollywood | J. Boggs | B. Hanley
[1] B. Olabi,et al. Response to ‘Long‐term outcomes of imiquimod‐treated lentigo maligna’ , 2020, Clincal and Experimental Dermatology.
[2] C. Lawrence,et al. Long‐term outcomes of imiquimod‐treated lentigo maligna , 2019, Clinical and experimental dermatology.
[3] B. Olabi,et al. Ten years’ experience using the Johnson square procedure for lentigo maligna , 2019, The British journal of dermatology.
[4] S. Koljenović,et al. Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery , 2019, The British journal of dermatology.
[5] G. Kravvas,et al. Eruptive melanocytic naevi secondary to azathioprine: case report and review of the literature , 2018, Clinical and experimental dermatology.
[6] S. Varma,et al. Johnson square procedure for lentigo maligna and lentigo maligna melanoma , 2014, Clinical and experimental dermatology.
[7] M. Davis,et al. Activating BRAF mutations in eruptive melanocytic naevi , 2010, The British journal of dermatology.
[8] D. Hoop,et al. Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals , 2006, The British journal of dermatology.
[9] L Lowe,et al. Usefulness of the staged excision for lentigo maligna and lentigo maligna melanoma: the "square" procedure. , 1997, Journal of the American Academy of Dermatology.